喜炎平与阿奇霉素在小儿支原体肺炎中的应用效果  

The Effect of Xiyanping Injection and Azithromycin in the Treatment of Mycoplasma Pneumonia in Children

作　　者：宋晓波[1] 

机构地区：[1]吉林省长春市儿童医院呼吸三科,吉林长春130000

出　　处：《中国卫生标准管理》2017年第27期116-118,共3页China Health Standard Management

摘　　要：目的探究喜炎平联合阿奇霉对小儿支原体肺炎的治疗效果。方法根据我院呼吸科2015年1月—2017年6月所收治的146例支原体肺炎患儿的资料,随机分为对照组(阿奇霉素)与实验组(喜炎平联合阿奇霉素),每组73例,观察期为2周,对比两组患儿的治疗效果。结果对比两组患儿的治疗效果及不良反应,实验组明显优于对照组,其对比结果差异具有统计学意义(P<0.05)。结论联合使用喜炎平和阿奇霉素能够显著提升治疗效果,降低药物不良反应的发生情况,加快治愈速度。Objective To explore the therapeutic effect of Xiyanping combined with azithromycin on mycoplasma pneumonia in children. Methods According to the data of 146 children with mycoplasma pneumonia in respiratory department admitted in our hospital from January 2015 to June 2017, they were randomly divided into control group （azithromycin） and experimental group （Xiyanping combined with azithromycin）. There were 73 cases in each group, and the observation period was 2 weeks. The treatment effect of two groups of children was compared. Results Compared the two groups of children＇s treatment effect and adverse reaction, the experimental group was significantly better than the control group, the difference between the two groups was statistically significant （P 〈 0.05）. Conclusion The combined use of Xiyanping and azithromycin can significantly improve the therapeutic effect, reduce the occurrence of adverse drug reactions, accelerate the cure rate.

关 键 词：支原体肺炎 小儿 阿奇霉素 喜炎平 临床观察 

分 类 号：R725[医药卫生—儿科]